Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ibuprofen 800 mg q6h for postoperative pain
2011-005007-33Phase 3Terminated
- Sponsor
- Biomendi
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ibuprofen i.v. 800 mg q6h with Placebo i.v. q6h (2 arms). Primary endpoint: Total morphine use in first 24 hours post-surgery. Started Dec 2011; status: terminated.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2011-005007-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005007-33.